Issuer · CIK 0000875320
VRTX — VERTEX PHARMACEUTICALS INC / MA
Recent filings
- Mar 13, 2026·Form 4·Sell$1.3M
VRTX/VERTEX PHARMACEUTICALS INC / MA
McKechnie Duncan · EVP, Chief Commercial Officer
32conviction - Feb 26, 2026·Form 4·Other$789.3K
VRTX/VERTEX PHARMACEUTICALS INC / MA
Atkinson Edward Morrow III · EVP, Chief Technical Ops. Off.
18conviction - Feb 19, 2026·Form 4·Sell$994.1K
VRTX/VERTEX PHARMACEUTICALS INC / MA
Atkinson Edward Morrow III · EVP, Chief Technical Ops. Off.
28conviction - Feb 18, 2026·Form 4·Other$1.1M
VRTX/VERTEX PHARMACEUTICALS INC / MA
Bunnage Mark E. · EVP, Chief Scientific Officer
scoring - Feb 18, 2026·Form 4·Other$1.1M
VRTX/VERTEX PHARMACEUTICALS INC / MA
McKechnie Duncan · EVP, Chief Commercial Officer
scoring - Feb 18, 2026·Form 4·Sell$133K
VRTX/VERTEX PHARMACEUTICALS INC / MA
Bhatia Sangeeta N. · director
18conviction